Results 211 to 220 of about 165,831 (308)

Editorial: Exploring immunological tolerance in allergy treatment through AIT. [PDF]

Front Immunol
Vizzardelli C.
europepmc   +1 more source

A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B‐Cell Lymphoma

American Journal of Hematology, EarlyView.
ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez, Mariana Bastos‐Oreiro, Catherine Diefenbach, Izidore S. Lossos, Nirav Shah, Sarit Assouline, Adam J. Olszewski, Seema Naik, Nilanjan Ghosh, Song Pham, Michael C. Wei, Connie Batlevi, Iris To, Wahib Ead, Sneha Makadia, Elicia Penuel, Jing Jing, Lihua E. Budde   +17 more
wiley   +1 more source

Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts. [PDF]

Allergy
Urbano MC, Vieira RJ, Xiang YK, Gil-Mata S, Bedbrook A, Abdullah B, Al-Ahmad M, Al-Nesf MA, Alvarez-Cuesta E, Amade SM, Asllani J, Bennoor KS, Berghea EC, Calvo-Gil M, Caraballo LR, Castro E, Cecchi L, Choudhury D, Christoff G, Chu DK, Cirule I, Cruz AA, Dokic D, Gemicioglu B, Guzman MA, Grisle I, Haahtela T, Hossny E, Hoetzenecker W, Hrubisko M, Iinuma T, Ispayeva Z, Ivancevich JC, Ko FWS, Kraxner H, Kupczyk M, Kvedariene V, Lam Y, Larenas-Linnemann DE, Mahboub B, Mahesh PA, Masjedi MR, McDonald G, Melendez A, Mihaltan F, Milenkovic B, Mohammad Y, Niedoszytko M, O'Hehir RE, Panaitescu C, Panzner P, Papadopoulos NG, Perez JMF, Pham-Thi N, Pitsios C, Plavec D, Repka-Ramirez MS, Romantowski J, Rostan MV, Rottem M, Salim H, Tantilipikorn P, Tomic-Spiric V, Valiulis A, Vecillas LL, Ventura MT, Wallace D, Werminghaus P, Williams S, Zamora FJP, Klimek L, Zuberbier T, Pereira AM, Fonseca JA, Bousquet J, Sousa-Pinto B.   +75 more
europepmc   +1 more source

Are Management Strategies Associated with Tolerance Acquisition in Infants with Cow's Milk-Induced Allergic Proctocolitis? [PDF]

J Clin Med
Sefer AP, Yorgun Altunbas M, Kaya MS, Baysal S, Kot H, Sasihuseyinoglu AS, Karali Y, Yalcin Gungoren E, Barca S, Ayhan YS, Karakoc-Aydiner E.   +10 more
europepmc   +1 more source

Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk‐Stratification and Management

American Journal of Hematology, EarlyView.
ABSTRACT Disease Overview The myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid disorders characterized by peripheral blood cytopenias and increased risk of transformation to acute myelogenous leukemia (AML). MDS occurs more frequently in older males and in individuals with prior exposure to cytotoxic therapy.
Guillermo Garcia‐Manero
wiley   +1 more source

Amoxicillin Direct Oral Challenge in Hospitalized Patients With High-Risk Allergic Reactions, in a Pharmacist-Directed Program. [PDF]

Open Forum Infect Dis
Le B, Joshi S, Tucker K, Ham YY.
europepmc   +1 more source

Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease

American Journal of Hematology, EarlyView.
ABSTRACT Chronic antigenic stimulation is implicated in the pathogenesis of monoclonal gammopathy and multiple myeloma, yet longitudinal human evidence linking sustained antigen exposure to modifiable clonal plasma cell evolution remains limited. Gaucher disease (GD), caused by biallelic GBA1 pathogenic variants, is characterized by accumulation of ...
Noor Ul Ain, Noffar Bar, Lilu Guo, Katherine Klinger, Punita Gupta, Atta Ur Rahman, Ruhua Yang, Yanhong Deng, Natalia Neparidze, Shiny Nair, Pramod K. Mistry   +10 more
wiley   +1 more source

Legends of Allergy & Immunology: A. Wesley Burks: Advocate for Children's Health Through Scientific Discovery. [PDF]

Allergy
Berin MC, Jones SM, Kim EH, Sampson HA.
europepmc   +1 more source

The IL‐10/IL‐6 Ratio and the Risk Score: Two Cytokines‐Based Predictors for Malignancy‐Associated Hemophagocytic Lymphohistiocytosis in Adults (M‐HLHa)

American Journal of Hematology, EarlyView.
ABSTRACT The predictive value of cytokines (CK) for malignancy‐associated adult hemophagocytic lymphohistiocytosis (M‐HLHa) remains uncertain. We evaluated a cytokine‐based Risk Score (RS) and the IL‐10/IL‐6 Ratio to predict M‐HLHa. Adult patients (n = 112) from the French HLH cohort (NCT02113917) with complete data for nine key HLH related CK measured
Coralie Bloch, Stephanie Chhun, Nanthara Sritharan, Marine Gil, Raphael Lhote, Marouane Boubaya, Olivier Lambotte, David Launay, Claire Larroche, Estibaliz Lazaro, Francois Liffermann, Marc Michel, Jean‐Marie Michot, Pierre Morel, Louis Terriou, Geoffrey Urbansk, Jean‐Francois Viallard, Morgane Cheminant, Felipe Suarez, Yves Lepelletier, Geneviève de Saint Basile, Olivier Hermine, the French HLH Study Group, Coralie Bloch, Jean Philippe Jais, Francois Liffermann, Pierre Morel, Morgane Cheminant, Felipe Suarez, Olivier Hermine, Fabrice Bonnet, Pascal Godemer, Damaj Gandhi, Olivier Fain, Olivier Lambotte, David Launay, Louis Terriou, Claire Larroche, Estibaliz Lazaro, Jean‐Francois Viallard, Francois Liffermann, Olivier Lortholary, Marc Michel, Jean‐Marie Michot, Pierre Morel, Frederic Pene, Antoinette Perlat, Geoffrey Urbanski   +47 more
wiley   +1 more source